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Abstract
Fibrinogen (Fg) has been recognized to play a central role in coagulation, inflammation and tissue regeneration. Several
studies have used Fg deficient mice (Fg
2/2) in comparison with heterozygous mice (Fg
+/2) to point the proinflammatory
role of Fg in diverse pathological conditions and disease states. Although Fg
+/2 mice are considered ‘normal’, plasma Fg is
reduced to ,75% of the normal circulating levels present in wild type mice (Fg
+/+). We report that this reduction in Fg
protein production in the Fg
+/2 mice is enough to protect them from kidney ischemia reperfusion injury (IRI) as assessed by
tubular injury, kidney dysfunction, necrosis, apoptosis and inflammatory immune cell infiltration. Mechanistically, we
observed binding of Fg to ICAM-1 in kidney tissues of Fg
+/+ mice at 24 h following IRI as compared to a complete absence
of binding observed in the Fg
+/2 and Fg
2/2 mice. Raf-1 and ERK were highly activated as evident by significantly higher
phosphorylation in the Fg
+/+ kidneys at 24 h following IRI as compared to Fg
+/2 and Fg
2/2 mice kidneys. On the other hand
Cyclin D1 and pRb, indicating higher cell proliferation, were significantly increased in the Fg
+/2 and Fg
2/2 as compared to
Fg
+/+ kidneys. These data suggest that Fg heterozygosity allows maintenance of a critical balance of Fg that enables
regression of initial injury and promotes faster resolution of kidney damage.
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Introduction
Fibrinogen (Fg) is a 340 kDa glycoprotein, a homodimer linked
by disulphide bonds with each unit comprising of 3 distinct
polypeptide chains (Aa,B b and c) that are encoded by 3 separate
genes (FGA, FGB and FGG) [1]. Apart from its prominent role in
the coagulation cascade, Fg serves as an acute phase response
protein by acting as a ligand for receptors expressed on cells
recruited to the site of inflammation [2]. In humans, several
polymorphisms have been described most of them clustered in the
FgB gene [3] resulting in chronically elevated levels of Fg [4,5].
Hyperfibrinogenemia (characterized by high circulating plasma
levels of Fg) is consistently associated with an increased risk of
cardiovascular diseases [6]; conversely, afibrinogenemia causes
severe hemorrhagic risks in affected patients [7]. This suggests the
necessity to maintain a critical balance in the levels of Fg that is
high enough to maintain adequate clot formation yet low enough
to reduce its interactions with cellular receptors along with
reducing the availability of fibrin matrices that act as centers of
migration and proliferation of immune and endothelial cells in
instances of acute and chronic inflammation.
The contribution of Fg in disease pathophysiology of various
organs has been studied using Fg deficient mice (Fg
2/2) that lack
the Aa chain, which precludes assembly of functional circulating
protein [8,9]. Fg deficient mice (Fg
2/2) that lack the Aa chain [8]
have shown to be protected from variety of injury/disease states
such as atherosclerosis [10], colitis [11], crescentric glomerulone-
phritis [12], Duchenne muscular dystrophy [13], endotoxemia
[14], fibrosis [15,16], multiple sclerosis [17], myocardial ischemia-
reperfusion injury [18], ischemic neurodegeneration [19] and
rheumatoid arthritis [20]. It should be noted that all of these
studies used littermate Fg
+/2 mice as experimental controls and
not as experimental groups for comparison. Although the Fg
+/2
mice do not show any symptoms of abnormal clotting and are for
all purposes ‘normal’ when compared to Fg
2/2 mice, the plasma
level of the Fg protein is reduced to ,75% of the normal
circulating levels present in wild type mice (Fg
+/+) [9]. The
reduction in Fg may not be significant enough to impair the
coagulation cascade but could still suffice to alter the binding
response to various cellular receptors thereby transforming the
immune system’s inflammatory response.
The objective of our study, therefore, was to evaluate the
expression profile of Fg following kidney ischemia reperfusion
injury (IRI) and to characterize the phenotype of the Fg
2/2 and
Fg
+/2 mice against animals homozygous for the Aa gene (Fg
+/+)i n
the context of kidney IRI.
Methods
Ethics
All animal maintenance and treatment protocols were in
compliance with the Guide for Care and Use of Laboratory
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e45628animals as adopted and promulgated by the National Institutes of
Health and were approved by the Harvard Medical School
Animal Care and Use Committees (IACUC).
Animals
Littermate male wild type (Fg
+/+), heterozygous (Fg
+/2) and
knock out (Fg
2/2) mice for fibrinogen on BALB/c background
(25–29 g) were used for the experiment [9]. Dr. Jay L. Degen at
Children’s Hospital Research Foundation, Cincinnati, Ohio,
kindly provided breeding pairs of genetically modified Fg mice.
Neonate mice experience spontaneous bleeding events, which
proves fatal only in 30–50% of cases (depending on strain) and
those who survive display otherwise normal organ physiology [9].
Experimental Design
In the first set of experiments twenty male BALB/c mice were
anesthetized using pentobarbital sodium (30 mg/kg, ip) and
subjected to 25 min bilateral IRI [21] for characterization of
fibrinogen expression and excretion. Mice were sacrificed at 24, 48
and 72 hours after reperfusion (n=5/timepoint). In the next set of
experiments genetically manipulated mice (54 male wild type,
heterozygous and knockout mice) were anesthetized as mentioned
above and subjected to 29 min of bilateral renal I/R surgery by
the retroperitoneal approach. Sham surgery was performed with
exposure of both kidneys but without induction of ischemia. Mice
(n=6/group/timepoint) in the respective groups (sham or I/R)
were injected with BrdU (50 mg/kg, ip) 3 hr prior to sacrifice.
Mice were sacrificed at 12 and 24 h following reperfusion using
overdose of pentobarbital (180 mg/kg, ip).
Serum creatinine (SCr) concentrations and blood urea nitrogen
(BUN) were measured using a VetScan VS2 (Abaxis, Union City,
CA). Plasma Fg (D-Dimer) test was performed by Asserachrom D-
Di ELISA kit from Diagnostica Stago, Inc. (Parsippany, NJ) as per
manufacturer’s instruction. Urinary Fg levels were measured using
commercially available Luminex assay based kit from Millipore
(Billerica, MA). Urinary creatinine concentration was used to
normalize fibrinogen in order to account for the influence of
urinary dilution.
Real Time PCR
Total RNA was extracted by TRIzol reagent (Invitrogen
Corporation) as per manufacturer’s protocol. Forward and reverse
primer sequences for mouse specific genes were designed using
MacVector software (MacVector Inc., Cary, NC) and are listed in
Table S1.
In situ Hybridization
Kidney, liver and heart cryosections were washed with TBS and
in situ hybridization was performed with universal digoxigenin
based in situ hybridization and detection kit as per manufacturer’s
instructions (Invitrogen, Carlsbad, CA). The probe sequences used
are as follows: Fga-AAT ATG CAA AGA TAG GCA TCA CCC
AGA TTG AAG TAG CTA CTG CCT ACC TGC CTG T;
Fgb-AGT ATA CTC TGT ACG GCT TGA TGG AGG TGT
CAG GCT GGA TGA GAT ACA TTT CGG A; Fgc-CTC AGT
GCA TAT GGA ATT GTG GAC TGC ATG CTT ATC AAA
TGA ATC TTC TCA TTT C.
Immunofluorescence Staining
Immunostainings in the frozen kidney sections was performed
using rat monoclonal anti-F4/80 a kind gift from Dr. Bonventre’s
laboratory, BWH, Boston, MA and rat monoclonal anti-BrdU
(Cell Signaling Technology, Danvers, MA). The primary antibody
was detected using donkey anti rat Cy3 labeled and donkey anti
rat FITC labeled secondary antibodies respectively (Jackson
ImmunoResearch Laboratories, West Grove, PA). DAPI (Sigma
Aldrich, St. Louis, MO) was used for nuclear staining. Apoptosis
was measured in kidney tissues by TUNEL assay using the In Situ
Cell Death detection kit (Roche Applied Science) according to
manufacturer’s instructions [22]. The images were captured by
Nikon DS-Qi1Mc camera attached to Nikon eclipse 90i fluores-
cence microscope using oil immersion objective 60/1.4 NA by
Nikon NIS elements AR ver 3.2 software.
Immunoblotting and Immunoprecipitation
Kidney tissues were homogenized in RIPA buffer [50 mM Tris-
HCl pH 7.4, 150 mM NaCl, 1% NP40, 1 mM PMSF, 1 mM
NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 1X protease inhibitor
cocktail (Roche Applied Science, Indianapolis, IN)] and equal
protein (30 mg) was resolved by polyacrylamide gel electrophoresis.
For plasma 0.02 ml was loaded on the gel. Proteins were
transferred onto nitrocellulose membrane and western blotting
was performed with rabbit polyclonal anti-fibrinogen (Dako),
mouse monoclonal anti-pERK, anti-ERK2 (BD Biosciences San
Diego, CA), anti-Cyclin D1, anti-pRb, anti-b -Actin (Cell
Signaling Technology), anti-a-Tubulin (Sigma) and goat poly-
clonal HRP conjugated anti-mouse albumin (Abcam, Cambridge,
MA). HRP conjugated secondary antibodies against mouse, rabbit
and goat was purchased from Jackson Immunoresearch (West
Grove, PA). For Immunoprecipitation (IP) tissues were lysed in IP
buffer (20 mM Tris-HCl pH 8.0, 137 mM NaCl, 10% glycerol,
1% NP-40, 2 mM EDTA) containing protease inhibitor cocktail
and 300 mg protein was incubated overnight at 4uC with 4 mgo f
rabbit polyclonal anti-fibrinogen antibody (Dako). Fifty microlitre
of protein A/G agarose was added and incubated for 2 h at room
temperature. Beads were washed thrice with IP buffer. Immune
complex was eluted by adding 1X SDS loading dye and heating at
100uC and western blot was performed to detect ICAM-1 (goat
polyclonal, R&D Systems) and goat polyclonal anti-fibrinogen
(Nordic lab, The Netherlands).
Statistics
Data are expressed as average + standard error. Statistical
difference (p,0.05) as calculated by one-way ANOVA or student’s
t-test. P,0.05 was considered significant and represented by ‘*’ as
compared to shams, ‘
#’ as compared to wild type at similar time
points, ‘
!’ as compared to heterozygous at similar time points
where applicable. All graphs were generated by GraphPad Prism
(GraphPad, Inc., La Jolla, CA).
Results
We found a significant increase in the mRNA (Fig. 1A, 1B),
protein expression (Fig. 1C) of Fg (Fga, Fgb and Fgc) in the kidney
and urinary excretion of Fg (Fig. 1D) in mice following IRI
corresponding to the kidney dysfunction and proximal tubular
necrosis (Fig. S1). In situ hybridization (ISH) with Fga, Fgb and Fgc
in the liver tissue revealed strong diffuse cytoplasmic staining in the
hepatocytes (Fig. 1B, biological positive control). In the kidney, the
staining varied in intensity and distribution between the chains
and with respect to the presence or absence of injury (Fig. 1B, first
two columns). Fga in uninjured (sham) kidney revealed diffuse
cytoplasmic staining that was less intense than the reactivity in
liver under the same conditions. The staining was more intense
and perinuclear in distribution 24 h after IRI. The staining was
more intense and perinuclear in distribution 24 h after IRI. ISH
for Fgb in uninjured kidney was as intense as in liver, but revealed
Fibrinogen Heterozygosity in Kidney Damage
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was of similar reactivity to Fga in distribution and intensity, in
uninjured and injured kidney; there was more diffuse cytoplasmic
staining in uninjured tissue, with less intense reactivity when
compared to the liver tissue, but in IRI, the reactivity intensified
and distributed around the nuclei, similar to the Fga.
Phenotypically the Fg
+/+, and mutant mice for FgA-a chain
[heterozygous (Fg
+/2)orknockout(Fg
2/2)]demonstratedfollowing
features (Fig. S2A): i) loss of Fga chain with, albeit modestly
decreased, but detectable transcription and translation of Fgb and
Fgc chains in the liver of Fg
2/2 mice (Fig. S2B) as reported
previously[9];ii)significantdecreaseintranscriptionandtranslation
ofFgaandFgbwithnoalterationsinFgcchaininthekidneyofFg
2/2
mice (Fig. S2C) as compared to Fg
+/+ mice; iii) approximately 50%
decrease in plasma Fg D-Dimer levels in Fg
+/2 mice and undetect-
ableFgproteininthecirculationin Fg
2/2miceascomparedtoFg
+/
+ (Fig. S2D); iv) unaltered urinary Fg protein excretion (Fig. S2E).
Following IRI, Fg
+/2 and Fg
2/2 mice showed greater kidney
dysfunction as assessed by BUN and SCr (Fig. 2A) at 12 h as
compared to Fg
+/+ mice (Fig. 2A). However, by 24 h the kidney
dysfunction in the Fg
+/+ and Fg
2/2 mice further escalated
whereas, the Fg
+/2 mice appeared to show rapid functional
restoration with BUN and SCr levels ,2–3 fold lower than the
Fg
+/+ and Fg
2/2 mice (Fig. 2A). Urinary Fg, serving as a sensitive
indicator of kidney tubular injury [21], also showed a massive
increase at 12 h in all three groups but significantly reduced levels
in Fg
+/2 (,5-fold) and Fg
2/2 (,10- fold) mice at 24 h as
compared to Fg
+/+ mice (Fig. 2A). Kidney histology showed severe
necrosis in the cortico-medullary junction of all post ischemic
kidneys particularly in the S3 segments at 12 and 24 h (Fig. 2B).
Although differences between the Fg
+/+, Fg
+/2 and Fg
2/2 mice in
the extent of necrosis were subtle, there was a marked reduction in
the number of apoptotic cells at 24 h in the Fg
+/2 and Fg
2/2 mice
as compared to Fg
+/+ mice (Fig. 2C).
We next evaluated the contribution of inflammatory immune
cell invasion in progression of kidney injury by immunostaining for
markers of macrophage (F4/80) and neutrophil (Ly-6G) in-
filtration. The number of F4/80 positive cells was similar at
12 h in all three groups but at 24 h the Fg
+/2 and Fg
2/2 mice
showed a statistically significant decrease in the number of
macrophages (Fig. 3A) as well as Ly-6G positive neutrophils
(Fig. S3) as compared to Fg
+/+ mice.
To evaluate the kidney tissue repair we quantitated the number
of proliferating epithelial cells by BrdU immunostaining and found
that Fg
+/2 and Fg
2/2 mice exhibited significantly greater number
of BrdU positive cells as compared to Fg
+/+ mice at 24 h (Fig. 3B).
This suggests that although the initiation and early phase of injury
was similar in all three groups there was a timely and efficient
tissue repair response in the Fg
+/2 and Fg
2/2 mice, which curbed
inflammation and apoptosis resulting in regression of injury. We
hypothesized that in the Fg
+/+ mice there is progression of the
initial injury because of Fg binding to Intercellular Adhesion
Molecule-1 (ICAM-1) that promotes apoptosis and cell death
through ERK phosphorylation.
We found that there was significant binding of Fg to ICAM-1 in
kidney tissues of Fg
+/+ mice at 24 h following IRI as compared to
a complete absence of binding observed in the Fg
+/2 and Fg
2/2
mice (Fig. 4A). Consistently there was a significant decrease in
expression of Fg protein at 24 h in Fg
+/2 and Fg
2/2 mice kidneys
as compared to Fg
+/+ mice following IRI (Fig. 4B). We further
confirmed Fg binding to ICAM-1 in tubular epithelial cells by co-
immunostaining that showed a Pearson co-localization coefficient
between Fg and ICAM-1 to be 0.6 in Fg
+/+ as compared to 0.4
and 0.05 in Fg
+/2 and Fg
2/2 respectively (Fig. S4). Raf-1 and
ERK were highly activated as evident by significantly higher
phosphorylation in the Fg
+/+ kidneys at 24 h following IRI as
compared to Fg
+/2 and Fg
2/2 mice kidneys. pERK was
upregulated at 12 h in all three groups confirming the earlier
observations (Fig. 2) about similar level of necrosis, apoptosis and
Figure 1. Transcription and translation of Fga, Fgb and Fgc in the kidney as urinary Fg excretion is significantly increased following
IRI in mice. To characterize the de novo expression of Fg at the mRNA and protein level in the kidney, male BALB/c were subjected to IRI and kidneys,
blood and urines were collected over time (n=5/time point). A) Real time PCR analysis in kidney for Fga, Fgb and Fgc chains, normalized to GAPDH,
and fold change determined over sham. B) In situ hybridization for Fga, Fgb and Fgc mRNA in kidney, 1:25 represents competition with unlabeled
probe, liver (positive control) and heart (negative control). C) Western blot analysis for Fg protein in the kidney. b-Actin served as loading control. D)
Urinary Fg levels measured by Luminex assay. *represents p,0.05 as determined by student’s t-test as compared to sham. Bar represents 10 mm.
doi:10.1371/journal.pone.0045628.g001
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hand Cyclin D1 and pRb, indicating higher cell proliferation, were
significantly greater at 24 h in the Fg
+/2 and Fg
2/2 as compared
to Fg
+/+ kidneys (Fig. 4B).
Discussion
Our results support the hypothesis that a reduction in
availability of excess Fg from interacting with ICAM-1 prevents
progression of injury thereby allowing timely induction of Cyclin
D1 and pRb mediating efficient kidney tissue repair and resolution
of injury (Fig. 4C). This hypothesis is consistent with the previous
reports demonstrating therapeutic potential of Fg-derived peptides
(Bb15–42 and c377–395) by competing with native Fg for binding to
vascular endothelial cadherin (VE-cadherin), ICAM-1, CD11b/
CD18 which in turn inhibits infiltration of leukocytes at the site of
injury and prevents exacerbation of injury [18,23]. Furthermore,
others and we have previously shown that Bb15–42 peptide
administration protected from kidney IRI by increasing tissue
repair and decreasing apoptosis [21,24] confirming that pharma-
cological reduction in excess Fg paves the way for faster structural
and functional recovery.
Figure 2. Fibrinogen heterozygosity protects from progression of kidney dysfunction and apoptosis following IRI. Male wild type
(Fg
+/+), heterozygous (Fg
+/2) and knock out (Fg
2/2) mice were subjected to IRI and assessed for kidney injury parameters (n=6/group/time point) A)
Serum creatinine (Scr), Blood Urea Nitrogen (BUN) and urinary Fg levels. B) Representative histopathological images using periodic acid-schiff (PAS)
staining and quantitative necrosis score represented graphically on the right. C) Apoptotic cells (green) determined by TUNEL assay. Percentage of
positive staining TUNEL nuclei is represented graphically on the right of photomicrographs. *represents p,0.05 in comparison to sham;
#represents
p,0.05 as compared to wild type within the time point and
!represents p,0.05 as compared to heterozygous within the time point as determined by
one-way ANOVA. Bar represents 10 mm.
doi:10.1371/journal.pone.0045628.g002
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PLOS ONE | www.plosone.org 4 September 2012 | Volume 7 | Issue 9 | e45628Figure 3. Heterozygous and knockout Fg mice exhibit efficient immune cell clearance coupled with robust tubular epithelial cell
proliferation. Fixed frozen sections following IRI were stained for A) macrophage F4/80 (red). Number of F4/80 cells per 60X field is represented
graphically on the right of the photomicrograph. B) BrdU positive cells (green) by immunofluorescence. Percentage of positive staining for BrdU
positive nuclei is represented graphically on the right of photomicrographs. Arrowheads indicate positive cells/nucleus and bar represents 10 mm.
*represents p,0.05 in comparison to sham;
#represents p,0.05 as compared to wild type within the time point and
!represents p,0.05 as compared
to heterozygous within the time point as determined by one-way ANOVA. Bar represents 10 mm.
doi:10.1371/journal.pone.0045628.g003
Fibrinogen Heterozygosity in Kidney Damage
PLOS ONE | www.plosone.org 5 September 2012 | Volume 7 | Issue 9 | e45628Figure 4. Fibrinogen binds to ICAM-1 in the kidney leading to sustained tissue injury. A) Kidney tissue lysates were immunoprecipitated
with anti-fibrinogen antibody and immunoblot was performed for ICAM-1. IgG light chain served as loading control for IP and b-Actin served as
loading control for input. B) Following 29 min IRI kidney tissue lysates were prepared and equal protein was resolved on SDS-PAGE for western blot
analysis for pERK, ERK, Cyclin D1 and pRb. a-Tubulin served as loading control. C) Schematic showing that in the Fg
+/2 mice a reduction in availability
of excess Fg from interacting with ICAM-1 prevents progression of injury thereby allowing timely induction of Cyclin D1 and pRb mediating efficient
kidney tissue repair and resolution of injury.
doi:10.1371/journal.pone.0045628.g004
Fibrinogen Heterozygosity in Kidney Damage
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is transcribed in the kidney and its mRNA levels, protein
expression and urinary excretion significantly increase following
IRI; ii) Heterozygosity of mouse FgAa chain results in global
reduction of Fg production to a moderate level that protects the
Fg
+/2 mice from IRI-induced kidney tubular injury, kidney
dysfunction, inflammation and apoptosis by launching an efficient
tissue regeneration response. Although Fg
2/2 mice showed
a reduction in apoptosis, reduced immune cell infiltration and
increased regeneration, the functional and structural restoration of
the kidney after IRI was not as rapid as Fg
+/2 mice potentially due
to the impedance with clotting.
Fibrinogen binding to ICAM-1 through its c117–133 domain has
been well documented on endothelial cells [25,26] and has been
shown to promote leukocyte transmigration by acting as an
intermediary molecule that can bind both ICAM-1 and leukocytes
through the Mac-1 receptor [27]. We extended these studies and
show that Fg binds to ICAM-1 in the kidney following IRI thereby
potentially activating Raf-1, triggering the Raf-MEK-ERK
pathway, which in turn can activate an apoptotic response.
Experiments using anti-ICAM-1 antibodies as well as ICAM-1–
deficient mice have shown ICAM-1 to be a key mediator of acute
IRI injury via potentiation of neutrophil–endothelial interactions
[28]. ICAM-1 expression significantly increases on proximal
tubular epithelial cells in patients with acute renal allograft
rejection [29] and here we found significant co-localization of
ICAM-1 with Fg (Pearson’s co-localization coefficient of 0.6, Fig.
S4) predominantly on the proximal tubular epithelial cells
emphasizing the paradigm that tubular epithelium is not merely
a passive victim of injury but also an active participant in the
inflammatory response in kidney IRI [30].
In summary, our experiment shows that kidney expresses Fga,
Fgb and Fgc transcripts and genetic manipulation resulting in
decreased availability of Fg protein to interact with cellular
receptors diminishes the molecular response cascade and dampens
the inflammatory response leading to faster resolution of injury.
Supporting Information
Figure S1 Characterization of kidney dysfunction and
tubular injury following bilateral renal ischemia/reper-
fusion injury (IRI). Male BALB/c were subjected to IRI and
kidneys, blood and urines were collected over time (n=5/time
point). A) Serum creatinine (Scr) and Blood Urea Nitrogen (BUN)
measurements. B) Representative histological H&E stained images
following IRI at 24, 48 and 72 h showing proximal tubular
necrosis as compared to sham. Bar represent 100 mm.
(TIF)
Figure S2 Genotype and phenotype characterization of
Fg wild type, heterozygous and knockout mice. A)
Genotyping results from a representative group (n=7) of Fg wild
type, heterozygous and knockout mice as described in methods
section. B) Real time PCR and Western Blot analysis for Fg (Fga,
Fgb and Fgc) in the liver and C) Kidney of Fg wild type,
heterozygous and knockout mice. D) Plasma levels of Fg in wild
type, heterozygous and knockout mice were measured by D-
Dimer ELISA test and by western blot analysis. E) Urinary levels
of Fg were measured using a Luminex based assay in wild type,
heterozygous and knockout mice. *represents p,0.05 as de-
termined by student’s t-test in comparison to wild type.
(TIF)
Figure S3 Heterozygous and knockout Fg mice show
significantly decreased neutrophil infiltration following
IRI. Fixed frozen section following IRI at 12 and 24 h were
stained for Ly-6G (green). Number of Ly-6G positive nuclei is
represented graphically on the right of photomicrographs. Arrow-
heads indicate neutrophils and bar represent 10 mm. *represents
p,0.05 in comparison to sham;
#represents p,0.05 as compared
to wild type within the time point and
!represents p,0.05 as
compared to heterozygous within the time point as determined by
one-way ANOVA. Bar represent 10 mm.
(TIF)
Figure S4 Significant colocalization of Fg and ICAM in
the kidney following IRI. Fixed frozen section following IRI at
12 and 24 h were co-stained for Fg (red) and ICAM-1 (green).
Pearson’s coefficient was plotted as a measure of co-localization on
the right of photomicrographs. *represents p,0.05 in comparison
to sham;
#represents p,0.05 as compared to wild type within the
time point and
!represents p,0.05 as compared to heterozygous
within the time point as determined by one-way ANOVA. Bar
represent 10 mm.
(TIF)
Table S1 Primer sequences for genotyping and Real
Time PCR analysis for candidate genes.
(DOC)
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